
Search
Filter Results
Displaying 471–480 of 645 for “retinal diseases”
-
Often diagnosed in childhood or adolescence, Stargardt disease is an inherited form of macular degeneration causing central vision loss. The condition is sometimes referred to as juvenile or early onset macular degeneration.
-
Best disease is an inherited retinal disease, which causes macular degeneration and loss of central vision, visual acuity, and color perception.
-
Jun 24, 2016
A Steady Hand in Saving Vision
Subretinal injection is the most common form of delivery for gene therapies currently in clinical trials.
-
Jun 18, 2025
José-Alain Sahel Awarded 2026 ARVO Proctor Medal for Groundbreaking Research Achievements
Dr. Sahel’s research has led to several emerging retinal disease therapies that have moved into clinical trials.
-
May 15, 2025
ARVO 2025 Highlight: J&J’s XLRP Gene Therapy Didn’t Meet Primary Endpoint in Phase 3 Clinical Trial
Despite missing the primary endpoint, the treatment improved vision for some patients.
-
Feb 24, 2025
LCA4 Gene Therapy Restores Meaningful Vision for Blind Children
MeiraGTx hopes to apply for marketing approval in the UK for the gene therapy.
-
There are many ways you can support the mission of the Foundation Fighting Blindness in finding treatments and cures for blinding diseases.
-
Join the Foundation Fighting Blindness for our new program, Vision Connection, an enriching and supportive gathering for the blind and low vision community.
-
May 22, 2024
ARVO 2024 Highlight: InGel’s Cell Therapy Shows Promise for Preserving Vision
The emerging treatment is designed to work for people with RP and other conditions regardless of the gene mutation causing disease
-
Feb 1, 2024
Ascidian to Launch Clinical Trial for Stargardt Disease RNA Editing Therapy
ACDN-01 is the only genetic medicine entering clinical development for Stargardt disease.